ABGD Ventures is a specialised venture capital group with deep expertise in healthtech and investment. We support innovative solutions born in emerging markets and help them scale into developed markets, including the US, EU, UK, GCC, and Africa. Our collective experience spans over five decades of healthtech and entrepreneurship, providing founders with practical company-building support and investors with outsized returns and real-time value creation.
We back purpose-driven founders who are committed to improving health outcomes through innovative solutions. Healthtech innovation from emerging markets must address critical care gaps in developed, high-value markets. By providing patient capital, access to healthcare ecosystems, and hands-on partnership, we create value for both founders and investors, turning promising innovation into a global enterprise with measurable social impact.
Invest early in transformative healthtech innovations from emerging markets and multiply impact by scaling these technologies into high-value global markets through a proven international growth playbook.
Clinical/business
need validation
Product design
validation
Prototype
Clinical trials
validation
Regulatory compliance
Risk management
Go-to-market support
Facilitate speed-to-market